Anders Kronborg has a diverse and extensive work experience spanning multiple industries and roles. Anders is currently the CEO of ResoTher Pharma and has been in this position since February 2023. Prior to that, they worked as a board member and senior adviser at Anders Kronborg Consulting starting in September 2022.
Anders Kronborg also has a background in the pharmaceutical industry, having served as the CFO/EVP at LEO Pharma from October 2015 to September 2022.
Before their work in the pharmaceutical sector, they held positions at Kinnevik Investment AB, Metro International, TV2 Denmark, Berlingske Media, DR, and the Ministry of Finance. These roles encompassed various executive and leadership positions, such as COO at Kinnevik Investment AB and CFO & EVP at Metro International.
Overall, Anders Kronborg's work experience showcases their expertise in finance, executive management, and consulting in a wide range of industries.
Anders Kronborg graduated from the University of Copenhagen in 1989 with a degree in Economics. Anders attended the university from 1984 to 1989.
February, 2023 - present